Insider Transactions in Q2 2021 at Kala Pharmaceuticals, Inc. (KALA)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 29
2021
|
Hongming Chen CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
5,548
-2.31%
|
$27,740
$5.56 P/Share
|
|
Jun 28
2021
|
Mark T Iwicki CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
7,586
-2.5%
|
$37,930
$5.77 P/Share
|
|
Jun 28
2021
|
Todd Bazemore |
SELL
Open market or private sale
|
Direct |
2,911
-2.12%
|
$14,555
$5.77 P/Share
|
|
Jun 28
2021
|
Mary Reumuth CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,452
-1.66%
|
$12,260
$5.77 P/Share
|
|
Jun 28
2021
|
Eric Trachtenberg |
SELL
Open market or private sale
|
Direct |
2,452
-1.91%
|
$12,260
$5.77 P/Share
|
|
Jun 28
2021
|
Romulus K Brazzell |
SELL
Open market or private sale
|
Direct |
3,034
-1.0%
|
$15,170
$5.77 P/Share
|
|
Jun 28
2021
|
Hongming Chen CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
2,452
-1.01%
|
$12,260
$5.77 P/Share
|
|
Jun 17
2021
|
Gregory Grunberg |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+33.33%
|
-
|
|
Jun 17
2021
|
Andrew I Koven |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+32.05%
|
-
|
|
Jun 17
2021
|
Robert Bradley Paull |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+33.33%
|
-
|
|
Jun 17
2021
|
Gregory D Perry |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+33.33%
|
-
|
|
Jun 17
2021
|
Howard B Rosen |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+30.85%
|
-
|
|
Jun 17
2021
|
Rajeev M. Shah |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+50.0%
|
-
|
|
Apr 01
2021
|
Ra Capital Management, L.P. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
1,687,709
+30.86%
|
$10,126,254
$6.74 P/Share
|